>http://www.newswise.com/articles/view/535281/
>"Interferon Does Not Slow or Stop Progression of Hepatitis C in Certain
[quoted text clipped - 6 lines]
>very fast.
>[...]
That's a nonsensical conclusion. The study only looked at patients that
already had severe fibrosis levels (Ishak score R3) before going into
treatment. They were on maintenance therapy because it was believed that
this might help stop progression to more severe levels. Unfortunately,
it did not. That's all this study shows.
Thomas

Signature
To reach me, complete my last name in the address.
Ghamph - 14 Nov 2007 19:39 GMT
> >http://www.newswise.com/articles/view/535281/
> >"Interferon Does Not Slow or Stop Progression of Hepatitis C in Certain
[quoted text clipped - 14 lines]
>
> Thomas
That was my impression on that also.
The candidates had quite advanced issues which would have been problematic
regardless.
A point of no return was reached that maintenance didn't stop.
Other treatments in the pipeline might show promise in the next few years.
Advanced status patients could try enrolling in studies,
Jamffer
mark - 19 Nov 2007 11:03 GMT
Hello Thomas Wagner,
In my previous note I pointed out that the HALT-C study found a high
rate of serious disease progression among those who had failed
combination therapy. Thanks for pointing out that the study group not
only had failed combination therapy but also had severe fibrosis. This
does not however change the conclusion that about 1/3 of the study
population progressed to severe symptoms in less than 4 years (and that
this rate was unaffected by maintenance interferon).
1/3 of a population becoming overtly and seriously ill in less than 4
years. That's a pretty rapid decline. You indicate a firm certainty
that the decline is what one would expect from people with HCV and
severe fibrosis. Any other conclusion is 'ridiculous.' But I've
personally seen several people decline rapidly from almost normally
functional to very ill right after combo therapy. So I've asked whether
the failed therapy and the rapid decline maybe are causally related.
It's not clear to me that we've got the data to answer whether the
decline is related to the failed therapy. However, I point to a very
recent 10/07 Medscape review "The Progressive Nature of Cirrhosis:
Implications for an Aging Hepatitis C-Infected Population." The article
indicates that one would expect progression from cirrhosis to
decompensation at about 4% per year. That's a lot lower than the rate
of decline found in the HALT-C study post failed combination therapy.
Mark
---------------
>> http://www.newswise.com/articles/view/535281/
>> "Interferon Does Not Slow or Stop Progression of Hepatitis C in Certain
[quoted text clipped - 14 lines]
>
> Thomas